Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31100039 | 0.88 | CRBN (0.50) | DDB1CRBN | |
| SCHEMBL31103338 | 0.88 | DDB1 (0.49) | DDB1CRBN | |
| SCHEMBL31102755 | 0.83 | DDB1 (0.47) | DDB1CRBN | |
| SCHEMBL31100054 | 0.81 | CRBN (0.43) | DDB1CRBN | |
| SCHEMBL31100431 | 0.77 | CRBN (0.48) | DDB1CRBN | |
| SCHEMBL31102583 | 0.77 | DDB1 (0.56) | DDB1CRBN | |
| SCHEMBL31103199 | 0.76 | CRBN (0.47) | DDB1CRBN | |
| SCHEMBL31103274 | 0.76 | CRBN (0.50) | DDB1CRBN | |
| SCHEMBL31102494 | 0.76 | DDB1 (0.47) | DDB1CRBN | |
| SCHEMBL31102736 | 0.75 | DDB1 (0.47) | DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678638-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-01-14 | — | — | EP | claimed |
| WO-2024188209-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-09-19 | — | — | WO | claimed |
| EP-4678638-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-01-14 | — | — | EP | disclosed |